3Derm Systems

Executive Summary

3Derm Systems, now a wholly owned subsidiary of Digital Diagnostics, is a US-based medtech company specializing in AI-powered dermatology diagnostics. Founded in 2012 and headquartered in New Haven, Connecticut, the company developed a proprietary imaging system and machine learning algorithms for remote skin cancer screening and triage. Its technology enables primary care providers to capture standardized skin lesion images that are analyzed by AI to prioritize high-risk cases for dermatologist review, thereby improving access to specialized care in underserved areas. The acquisition by Digital Diagnostics, a leader in AI-driven healthcare, provides 3Derm with expanded resources, a broader commercial platform, and potential synergies with Digital Diagnostics' existing FDA-cleared autonomous AI systems. While 3Derm's specific product status is not publicly detailed, the combination positions it to accelerate the deployment of dermatology AI solutions across Digital Diagnostics' network of clinics and telehealth partners. Looking ahead, the company's success will hinge on integrating its technology into Digital Diagnostics' portfolio, securing regulatory clearances for updated algorithms, and demonstrating real-world clinical utility in reducing skin cancer mortality.

Upcoming Catalysts (preview)

• Q3 2026FDA clearance for next-generation AI algorithm60% success
• Q4 2026Commercial launch through Digital Diagnostics partner network70% success
• Q2 2026Publication of prospective clinical validation study80% success